Moderna Inc

Here’s why Covid vaccines will still be free for uninsured Americans as public health emergency ends
A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images Uninsured Americans can still access Covid-19 vaccines at no cost, for now, even though the U.S. public health emergency has […]
Read More
Pfizer CEO says Medicare will likely face legal action over drug price negotiations
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021. John Thys | AFP | Getty Images Pfizer CEO Albert Bourla on Thursday said pharmaceutical companies […]
Read More
Novavax shares rise after company unveils positive vaccine data, plan to cut 25% of workforce
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Shares of Novavax rose 5% in premarket trading Tuesday after the company unveiled promising new vaccine data and a […]
Read More
Moderna posts surprise quarterly profit despite waning demand for Covid vaccines
Moderna’s sign is seen outside of their headquarters in Cambridge, MA on March 11, 2021. Boston Globe | Getty Images Moderna on Thursday blew past estimates for first-quarter earnings and revenue, posting a surprise quarterly profit, despite lower demand for Covid vaccines, its only marketable product. The biotech company generated first-quarter sales of $1.9 billion, […]
Read More
FDA approves GSK’s RSV vaccine for older adults, world’s first shot against virus
A GSK lab in London. Oli Scarff | Getty Images The Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages 60 and older. The approval, the first ever globally by a regulatory body for an RSV vaccine, is a decisive victory for GSK in a race […]
Read More
Marriott, Moderna and additional: CNBC’s ‘Halftime Report’ traders remedy your concerns
On Thursday’s “Ask Halftime,” our traders answered issues from CNBC Pro subscribers about stocks, bonds and ETFs all through this period of time of heightened sector volatility, together with regardless of whether to get, promote or hold specific names. Jason Snipe of Odyssey Money Advisors reviewed Marriott and why he expects there is continue to upside for […]
Read More
Merck revenue falls after dramatic drop in sales of Covid antiviral treatment
Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on October 4, 2021. NurPhoto | NurPhoto | Getty Images Merck on Thursday reported first-quarter revenue that fell 9% from the same period a year ago largely due to a steep drop in sales […]
Read More
Stocks making the biggest moves midday: Tesla, IBM, American Express, AT&T and more
Pedestrians walk through a street crossing in front of the American electric company car Tesla Motors official authorized car dealer store in Hong Kong, July 13, 2022. Budrul Chukrut | SOPA Images | Lightrocket | Getty Images Check out the companies making headlines in midday trading. Tesla — Shares tumbled nearly 9%. The action comes […]
Read More
Moderna teams up with IBM to put AI, quantum computing to work on mRNA technology used in vaccines
Sopa Images | Lightrocket | Getty Images Moderna and IBM are teaming up to use generative artificial intelligence and quantum computing to advance mRNA technology, the development at the core of the company’s blockbuster Covid vaccine, the companies announced Thursday. “We are excited to partner with IBM to develop novel AI models to advance mRNA […]
Read More
Abbott Labs shares pop as revenue, earnings defy steep drop in Covid test sales
The Abbott manufacturing facility in Sturgis, Michigan, on May 13, 2022. Jeff Kowalsky | AFP | Getty Images Shares of Abbott Laboratories popped Wednesday after the company’s earnings and revenue topped Wall Street’s expectations, defying a dramatic slowdown in sales of its Covid-19 tests. The medical products company posted adjusted earnings per share of $1.03. […]
Read More